VERA THERAPEUTICS INC's ticker is VERA and the CUSIP is 92337R101.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $77,000 | +42.6% | 5,591 | +67.4% | 0.00% | – |
Q2 2023 | $54,000 | +315.4% | 3,339 | +94.8% | 0.00% | – |
Q1 2023 | $13,000 | -73.5% | 1,714 | -32.3% | 0.00% | – |
Q4 2022 | $49,000 | +226.7% | 2,533 | +277.5% | 0.00% | – |
Q3 2022 | $15,000 | +87.5% | 671 | +16.1% | 0.00% | – |
Q2 2022 | $8,000 | -75.0% | 578 | -56.9% | 0.00% | – |
Q1 2022 | $32,000 | -55.6% | 1,341 | -50.3% | 0.00% | – |
Q4 2021 | $72,000 | +453.8% | 2,696 | +245.6% | 0.00% | – |
Q3 2021 | $13,000 | – | 780 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Abingworth LLP | 2,960,231 | $57,280,470 | 18.66% |
Kynam Capital Management, LP | 1,409,098 | $27,266,046 | 4.18% |
Sofinnova Investments, Inc. | 3,181,442 | $61,560,903 | 3.65% |
Octagon Capital Advisors LP | 665,156 | $12,870,769 | 2.00% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 281,257 | $5,428,260 | 1.68% |
Vivo Capital, LLC | 400,666 | $7,753 | 0.89% |
Eversept Partners, LP | 411,308 | $7,958,810 | 0.70% |
Logos Global Management LP | 285,000 | $5,514,750 | 0.65% |
Alphabet Inc. | 301,580 | $5,835,573 | 0.34% |
CARNEGIE MELLON UNIVERSITY | 16,060 | $310,761 | 0.17% |